Best LDL cholesterol goal after small vessel stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial is testing the best target for 'bad' cholesterol (LDL) after a type of stroke caused by a small blocked vessel. You would be in one of two groups to see which LDL level helps prevent another stroke the most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You've had a stroke from a small blocked blood vessel deep in the brain or brainstem, confirmed by MRI or CT scan, within the last 6 months.
- You are willing to take statins and do not have a condition that makes statins unsafe for you (like liver disease, muscle problems, or an allergy).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have another medical condition that requires you to already keep your LDL cholesterol very low (below 70 mg/dL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for people who recently had a stroke or TIA and have high cholesterol with artery plaque. Some participants will get a combination of two cholesterol-lowering medicines (statin and ezetimibe), while others will get only a statin.
This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This trial tests a smart computer tool that helps doctors manage your cholesterol treatment with Evolocumab (Repatha). If you have had a recent stroke or mini-stroke and are already taking this medicine, the tool may help you reach your LDL (bad cholesterol) goal faster.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
This study is for people who recently had a stroke or TIA and have high cholesterol. It aims to see how well different cholesterol-lowering treatments work to prevent another stroke.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.